142 related articles for article (PubMed ID: 2889976)
1. Tamoxifen and benign breast problems.
Fentiman IS; Powles TJ
Lancet; 1987 Nov; 2(8567):1070-2. PubMed ID: 2889976
[TBL] [Abstract][Full Text] [Related]
2. Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial.
Fentiman IS; Caleffi M; Hamed H; Chaudary MA
Br J Surg; 1988 Sep; 75(9):845-6. PubMed ID: 3052691
[TBL] [Abstract][Full Text] [Related]
3. Double-blind controlled trial of tamoxifen therapy for mastalgia.
Fentiman IS; Caleffi M; Brame K; Chaudary MA; Hayward JL
Lancet; 1986 Feb; 1(8476):287-8. PubMed ID: 2868162
[TBL] [Abstract][Full Text] [Related]
4. Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats.
Greaves P; Goonetilleke R; Nunn G; Topham J; Orton T
Cancer Res; 1993 Sep; 53(17):3919-24. PubMed ID: 8358718
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen: use in benign conditions.
Fentiman IS
Br J Clin Pract; 1988 Sep; 42(9):384-7. PubMed ID: 3075930
[No Abstract] [Full Text] [Related]
6. [Mastalgia treatment with tamoxifen].
Ortíz-Mendoza CM; Lucas Flores MA; Domville Ede G
Ginecol Obstet Mex; 2003 Oct; 71():502-7. PubMed ID: 15002689
[TBL] [Abstract][Full Text] [Related]
7. The tamoxifen dilemma.
White IN
Carcinogenesis; 1999 Jul; 20(7):1153-60. PubMed ID: 10383884
[TBL] [Abstract][Full Text] [Related]
8. Effects of tamoxifen on benign breast disease in women at high risk for breast cancer.
Tan-Chiu E; Wang J; Costantino JP; Paik S; Butch C; Wickerham DL; Fisher B; Wolmark N
J Natl Cancer Inst; 2003 Feb; 95(4):302-7. PubMed ID: 12591986
[TBL] [Abstract][Full Text] [Related]
9. Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.
Nelson HD; Smith ME; Griffin JC; Fu R
Ann Intern Med; 2013 Apr; 158(8):604-14. PubMed ID: 23588749
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and the prevention of breast cancer with tamoxifen.
Morrow M; Jordan VC
Cancer Surv; 1993; 18():211-29. PubMed ID: 8012998
[TBL] [Abstract][Full Text] [Related]
11. [Tamoxifen in the treatment of breast cancer].
Charlier C; Colin C; Merville MP; Gielen J; Lambotte R; Plomteux G; Castronovo V
J Gynecol Obstet Biol Reprod (Paris); 1994; 23(7):751-6. PubMed ID: 7822705
[TBL] [Abstract][Full Text] [Related]
12. The tamoxifen controversy--clinical chemopreventive agent and experimental carcinogen.
Pitot HC
Proc Soc Exp Biol Med; 1995 Feb; 208(2):139-40. PubMed ID: 7831344
[No Abstract] [Full Text] [Related]
13. A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinoma.
Longstaff S; Sigurdsson H; O'Keeffe M; Ogston S; Preece P
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1805-8. PubMed ID: 2632262
[TBL] [Abstract][Full Text] [Related]
14. A phase II trial of Afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women.
Mansel R; Goyal A; Nestour EL; Masini-Etévé V; O'Connell K;
Breast Cancer Res Treat; 2007 Dec; 106(3):389-97. PubMed ID: 17351746
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen and cataracts: a null association.
Bradbury BD; Lash TL; Kaye JA; Jick SS
Breast Cancer Res Treat; 2004 Sep; 87(2):189-96. PubMed ID: 15377843
[TBL] [Abstract][Full Text] [Related]
16. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral content of women receiving tamoxifen for mastalgia.
Fentiman IS; Caleffi M; Rodin A; Murby B; Fogelman I
Br J Cancer; 1989 Aug; 60(2):262-4. PubMed ID: 2765377
[TBL] [Abstract][Full Text] [Related]
18. [Is there a basis for prevention of breast cancer with drugs?].
Klemetsdal B
Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1493-5. PubMed ID: 9198929
[TBL] [Abstract][Full Text] [Related]
19. Overview of the main outcomes in breast-cancer prevention trials.
Cuzick J; Powles T; Veronesi U; Forbes J; Edwards R; Ashley S; Boyle P
Lancet; 2003 Jan; 361(9354):296-300. PubMed ID: 12559863
[TBL] [Abstract][Full Text] [Related]
20. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
Sharma R; Hamilton A; Beith J
Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
